Hwaseong, South Korea

Jungho Jang

This inventor holds 1 USPTO granted patent. Top assignees: Hyundai Motor Company, Kia Motors Corporation. Active years: 2018.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jungho Jang: Innovator in Engine Control Technology

Introduction

Jungho Jang is a notable inventor based in Hwaseong, South Korea. He has made significant contributions to the field of engine control technology, particularly through his innovative patent that enhances engine performance.

Latest Patents

Jungho Jang holds a patent for a "Method of controlling electric continuous variable valve timing apparatus." This method improves the starting performance of an engine by simplifying the phase control for the camshaft. The process involves determining whether the engine needs to start during driving, recognizing the target phase of the camshaft for the next engine start, and controlling the camshaft's phase to advance the intake timing accordingly. The phase control concludes based on the engine's or camshaft's state. This innovation is crucial for optimizing engine efficiency and performance.

Career Highlights

Throughout his career, Jungho Jang has worked with prominent automotive companies, including Hyundai Motor Company and Kia Motors Corporation. His experience in these organizations has allowed him to develop and refine his expertise in engine technologies.

Collaborations

Jungho Jang has collaborated with talented individuals in the industry, including Dong Hee Han and Hyun Jun Lim. These partnerships have contributed to the advancement of his innovative projects.

Conclusion

Jungho Jang's contributions to engine control technology through his patent demonstrate his commitment to innovation in the automotive field. His work continues to influence the development of more efficient engine systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…